StockWatch
·
Pharmaceuticals
AGM/EGM7 Sept 2026, 06:50 pm

Panacea Biotec Ltd Announces 42nd AGM and FY26 Annual Report

AI Summary

Panacea Biotec Ltd has announced its 42nd Annual General Meeting (AGM) scheduled for September 29, 2026, to be held via Video Conferencing. The company has also released its Annual Report for the financial year 2025-26. The AGM will include the adoption of audited standalone and consolidated financial statements for FY26, re-appointment of directors Mr. Ankesh Jain and Mr. Harshet Jain, and the appointment of Mr. Rajinder Singh Manku as an independent director. Shareholders will have the opportunity to participate in remote e-voting from September 26 to September 28, 2026, with a cut-off date of September 22, 2026, for eligibility.

Key Highlights

  • 42nd AGM scheduled for September 29, 2026, via VC/OAVM.
  • Annual Report for FY 2025-26 released.
  • Adoption of FY26 financial statements on the agenda.
  • Director re-appointments and new independent director appointment.
  • Remote e-voting facility available for shareholders.